Frankfurt - Delayed Quote EUR
Chemomab Therapeutics Ltd. (2QV0.F)
1.0900
+0.0300
+(2.83%)
At close: April 25 at 3:29:01 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
14,739
14,739
25,459
28,533
12,367
Operating Income
-14,739
-14,739
-25,459
-28,533
-12,367
Net Non Operating Interest Income Expense
794
794
1,238
353
-111
Pretax Income
-13,945
-13,945
-24,221
-28,180
-12,478
Tax Provision
--
--
--
-534
--
Net Income Common Stockholders
-13,945
-13,945
-24,221
-27,646
-12,478
Diluted NI Available to Com Stockholders
-13,945
-13,945
-24,221
-27,646
-12,478
Basic EPS
-0.78
--
-2.06
-2.42
-1.20
Diluted EPS
-0.78
--
-2.06
-2.42
-1.20
Basic Average Shares
17,952.4320
--
11,749.9430
11,379.4640
10,373.4320
Diluted Average Shares
17,952.4320
--
11,749.9430
11,379.4640
10,373.4320
Rent Expense Supplemental
50
50
81
24
29
Total Expenses
14,739
14,739
25,459
28,533
12,367
Net Income from Continuing & Discontinued Operation
-13,945
-13,945
-24,221
-27,646
-12,478
Normalized Income
-13,945
-13,945
-24,221
-27,646
-12,478
Net Interest Income
794
794
1,238
353
-111
EBIT
-14,739
-14,739
-25,459
-28,533
-12,367
EBITDA
-14,686
-14,686
-25,392
-28,475
-12,333
Reconciled Depreciation
53
53
67
58
34
Net Income from Continuing Operation Net Minority Interest
-13,945
-13,945
-24,221
-27,646
-12,478
Normalized EBITDA
-14,686
-14,686
-25,392
-28,475
-12,333
Tax Rate for Calcs
--
--
--
0
--
12/31/2021 - 5/19/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PBN.F Alterity Therapeutics Limited
0.0045
+12.50%
6XY.F HBM Holdings Limited
0.9000
+5.88%
FAB.L Fusion Antibodies plc
6.80
-9.09%
TRMED.OL Thor Medical ASA
2.4000
-2.24%
ELIC.ST Elicera Therapeutics AB (publ)
4.3500
+13.73%
FARN.L Faron Pharmaceuticals Oy
202.00
-0.25%
BIOVIC-B.ST Biovica International AB (publ)
0.6980
+9.06%
MEDCL.PA MedinCell S.A.
14.97
+0.13%
VVY.AS Vivoryon Therapeutics N.V.
1.7760
-1.88%
MDCLF MedinCell S.A.
6.98
0.00%